These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6810624)

  • 1. Cell-mediated immunity in chronic myelocytic leukemia.
    Hernández P; Cruz C; Fernández NL; Santos MN; Ballester JM
    Acta Haematol; 1982; 67(4):249-54. PubMed ID: 6810624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell membrane markers and phytohemagglutinin reactivity of circulating lymphocytes from chronic myelocytic leukemia patients.
    Rambotti P; Liberati AM; Velardi A; Ballatori E; Martelli MF; Grignani F; Davis S
    Cancer; 1982 Feb; 49(4):708-13. PubMed ID: 6948603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunologic dysfunction in Sickle cell anaemia.
    Hernández P; Cruz C; Santos MN; Ballester JM
    Acta Haematol; 1980; 63(3):156-61. PubMed ID: 6769281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibody-defined T-cell phenotypes and phytohemagglutinin reactivity of E-rosette-forming circulating lymphocytes from untreated chronic myelocytic leukemia patients.
    Velardi A; Rambotti P; Cernetti C; Spinozzi F; Gerli R; Martelli MF; Davis S
    Cancer; 1984 Feb; 53(4):913-6. PubMed ID: 6607098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Determination of active T lymphocytes in the peripheral blood by the AE rosette test. Correlation of the AE and E rosette tests with lymphocyte reactivity in vitro after PHA stimulation].
    Karwowska W; Kunicka A
    Probl Med Wieku Rozwoj; 1982; 11():111-6. PubMed ID: 6983690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hodgkin's disease. T lymphocyte defect in patients in complete remission (author's transl)].
    Lang JM; Bigel P; Oberling F; Mayer S
    Pathol Biol (Paris); 1978; 26(3-4):159-62. PubMed ID: 355984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hodgkin's disease. T lymphocyte defect in patients in complete remission (author's transl)].
    Lang JM; Bigel P; Oberling F; Mayer S
    Sem Hop; 1978 Nov 8-15; 54(37-40):1155-8. PubMed ID: 217096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Letter: Splenic lymphocytes in chronic granulocytic leukaemia.
    Kaur J; Spiers AS; Galton DA
    Lancet; 1975 Jul; 2(7923):40. PubMed ID: 49639
    [No Abstract]   [Full Text] [Related]  

  • 9. [Subpopulations of peripheral blood T-lymphocytes in patients with chronic glomerulonephritis].
    Rakitianskaia IA
    Urol Nefrol (Mosk); 1989; (4):55-8. PubMed ID: 2800080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-mediated immunity (CMI) in psoriasis.
    Gliński W; Haftek M; Obałek S; Jabłońska S
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):755-60. PubMed ID: 312084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-mediated and humoral types of immunologic immunity in idiopathic pancytopenia.
    Traczyk Z; Orczyńska E; Cieśluk S
    Arch Immunol Ther Exp (Warsz); 1979; 27(1-2):1-7. PubMed ID: 312631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration in cell-mediated immunity in patients with chronic active hepatitis. I. Lymphocyte subpopulations.
    Ponzetto A; Arrigoni A
    G Batteriol Virol Immunol; 1979; 72(1-6):28-32. PubMed ID: 317950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of alcohol on the lymphocyte system. V. Evaluation of blast transformation and rosette formation of peripheral blood lymphocytes in alcoholics].
    Pietruczuk M; Dabrowska M; Wołosowicz N; Hryniewicz K
    Przegl Lek; 1990; 47(4):389-93. PubMed ID: 2217854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Various indicators of cellular and humoral immunity in patients with myelocytic leukemia and subleukemia].
    Kravchenko NI; Tishchenko LM; Guseva SA; Belen'kaia MI
    Vrach Delo; 1985 Feb; (2):80-3. PubMed ID: 3873137
    [No Abstract]   [Full Text] [Related]  

  • 15. Stimulating capacity of blast cells from patients with chronic myelocytic leukaemia, in blastic crisis in 'one-way' mixed lymphoycte reaction: lack of evidence for T lymphoblastic conversion.
    Han T; Gomez GA; Minowada J
    Immunology; 1978 Aug; 35(2):299-305. PubMed ID: 155646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cell-mediated immunity after head injuries].
    Członkowska A; Korlak J
    Neurol Neurochir Pol; 1979; 13(4):389-93. PubMed ID: 314601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Some aspects of cell-mediated hypersensitivity in patients with melanoma.
    Moszkowska G; Jassem J; Kondrat W; Kopacz A; Goszczyńska E
    Arch Immunol Ther Exp (Warsz); 1980; 28(4):655-60. PubMed ID: 6970028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-mediated immunity in pregnancy evaluated using lymphocyte transformation tests and rosette tests for T and B lymphocytes. A cross-section analysis.
    Birkeland SA; Kristoffersen K
    Int Arch Allergy Appl Immunol; 1978; 56(3):232-7. PubMed ID: 304444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular immunity in patients with leprosy. Circulating T lymphocytes and their response to PHA in leprosy.
    Kaklamanis E; Drouga M; Kouzoutzakoglou K; Karalis D; Trichopoulos D
    Int J Lepr Other Mycobact Dis; 1977; 45(3):241-7. PubMed ID: 303622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humoral and cellular immunity in progressive systemic sclerosis.
    Sierakowski S; Bernacka K
    Med Interne; 1987; 25(4):233-8. PubMed ID: 3501150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.